Effectiveness and safety of oral direct factor Xa inhibitors for the treatment of venous thromboembolism in patients with cancer and/or older age-Reference-Cited by-同舟云学术

Effectiveness and safety of oral direct factor Xa inhibitors for the treatment of venous thromboembolism in patients with cancer and/or older age

Published:2018-10-19 Issue:4 Volume:34 Page:678-687
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Sato Daisuke,Ikeda Satoshi^ORCID,Koga Seiji,Yamagata Yuki,Eguchi Masamichi,Yonekura Tsuyoshi,Tsuneto Akira,Yoshimuta Tsuyoshi,Koide Yuji,Kawano Hiroaki,Maemura Koji

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-018-1283-5.pdf

Reference33 articles.

1. Goldhaber SZ, Bounameaux H (2012) Pulmonary embolism and deep vein thrombosis. Lancet 379:1835–1846

2. Nakamura M, Yamada N, Ito M (2015) Current management of venous thromboembolism in Japan: current epidemiology and advances in anticoagulant therapy. J Cardiol 66:451–459

3. Crous-Bou M, Harrington LB, Kabrhel C (2016) Environmental and genetic risk factors associated with venous thromboembolism. Semin Thromb Hemost 42:808–820

4. Blom JW, Doggen CJ, Osanto S, Rosendaal FR (2005) Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 293:715–722

5. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O’Fallon WM, Melton LJ III (2000) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160:809–815

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of acute thrombus regression effect of edoxaban for deep vein thrombosis in patients with cancer: a single-center prospective observational study;Heart and Vessels;2024-05-21

3. Efficacy and Safety of Rivaroxaban Therapy for Patients With Peripheral Artery Disease: A Systematic Review and Meta-Analysis;Vascular and Endovascular Surgery;2021-05-25

4. Current use of rivaroxaban in elderly patients with venous thromboembolism (VTE);Journal of Thrombosis and Thrombolysis;2021-03-05